SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000947871-19-000115
Filing Date
2019-02-14
Accepted
2019-02-14 15:59:03
Documents
4
Group Members
ANDREW H. WARFORDLEE S. AINSLIE IIIMAVERICK CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO 1 ss125830_sc13ga.htm SC 13G/A 134078
2 POWER OF ATTORNEY ss125830_ex24a.htm EX-24.A 3590
3 POWER OF ATTORNEY ss125830_ex24b.htm EX-24.B 4199
4 JOINT FILING AGREEMENT ss125830_ex99a.htm EX-99.A 21677
  Complete submission text file 0000947871-19-000115.txt   165290
Mailing Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201
Business Address 1900 N. PEARL STREET, 20TH FLOOR DALLAS TX 75201 214.880.4050
MAVERICK CAPITAL LTD (Filed by) CIK: 0000934639 (see all company filings)

IRS No.: 000000000 | State of Incorp.: TX
Type: SC 13G/A

Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
Impax Laboratories, LLC (Subject) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48867 | Film No.: 19605719
SIC: 2834 Pharmaceutical Preparations